NOTE: This supplement is only available to read in selected countries and geographies
[geoip-content country=”AT, BE, BG, HR, CY, CZ, DK, EE, FI, FR, DE, GR, HU, IE, IT, LV, LT, LU, MT, NL, PL, PT, RO, SK, SI, CH, ES, SE, GB, AL, AD, AM, AZ, BY, BA, GE, IS, KZ, LI, MD, MC, ME, MK, NO, RU, SM, RS, CH, TR, UA, VA”]
In this supplement, sponsored by Medtronic:
- Fabio Verzini discusses his clinical experience with the new Valiant Navion™ thoracic stent graft, one year after its launch
- Santi Trimarchi considers how the Valiant Navion™ thoracic stent graft offers a new technological solution to address unmet clinical needs in the treatment of a fragile aorta
- BIBA MedTech Insights survey results reveal which proximal features of a thoracic stent graft physicians prefer when treating type B aortic dissections
- A consensus document on the application of Heli-FX EndoAnchor implants to improve complex TEVAR outcomes, by Vincent Riambau, Robin Heijmen, Hervé Rousseau, Theodoros Kratimenos, and Andrés Reyes
[/geoip-content]
